GEODE CAPITAL MANAGEMENT, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 82 filers reported holding SEELOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$223,019
-84.0%
1,211,726
+3.8%
0.00%
Q2 2023$1,394,451
+77.3%
1,166,905
+2.5%
0.00%
Q1 2023$786,586
+103808.3%
1,138,001
+2.0%
0.00%
Q4 2022$757
-99.9%
1,115,883
+0.7%
0.00%
Q3 2022$1,141,000
+67.5%
1,107,829
+10.6%
0.00%
Q2 2022$681,000
-49.7%
1,001,597
-38.1%
0.00%
Q1 2022$1,355,000
-47.5%
1,617,707
+2.1%
0.00%
Q4 2021$2,583,000
-37.7%
1,584,988
-7.9%
0.00%
-100.0%
Q3 2021$4,149,000
+15.5%
1,721,677
+26.5%
0.00%
Q2 2021$3,592,000
+32.6%
1,360,649
+150.6%
0.00%
Q1 2021$2,709,000
+450.6%
542,954
+74.2%
0.00%
Q4 2020$492,000
+241.7%
311,618
+101.8%
0.00%
Q3 2020$144,000
-7.1%
154,3970.0%0.00%
Q2 2020$155,000
+106.7%
154,3970.0%0.00%
Q1 2020$75,000
-81.8%
154,397
-50.0%
0.00%
Q4 2019$412,000
+192.2%
308,794
+100.9%
0.00%
Q3 2019$141,000
-58.0%
153,7070.0%0.00%
Q2 2019$336,000
+160.5%
153,707
+298.4%
0.00%
Q1 2019$129,000
+50.0%
38,578
-91.6%
0.00%
Q4 2018$86,000456,8320.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 508,000$249,0000.10%
1492 Capital Management LLC 150,000$74,0000.09%
Uniplan Investment Counsel, Inc. 2,069,121$1,014,0000.08%
ARDSLEY ADVISORY PARTNERS LP 70,000$34,0000.01%
Spark Investment Management LLC 35,210$17,0000.01%
TOCQUEVILLE ASSET MANAGEMENT L.P. 191,000$94,0000.00%
WealthPLAN Partners, LLC 20,000$15,0000.00%
Procyon Advisors, LLC 2,500$1,0000.00%
Renaissance Technologies 1,078,379$529,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SEELOS THERAPEUTICS INC shareholders